Naturhouse Health SA

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: ES0105043006
EUR
2.12
0.01 (0.47%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'22
Jun'21
Mar'21
Dec'20
Sep'20
Jun'20
Mar'20
Net Sales
30.33
17.55
14.56
12.00
14.86
11.55
16.67
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
30.33
17.55
14.56
12.00
14.86
11.55
16.67
Raw Material Cost
15.28
8.29
7.56
6.84
8.90
8.40
13.57
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
5.48
2.80
2.56
3.49
2.60
2.07
4.21
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.10
0.09
0.00
0.00
0.05
0.05
0.00
Selling and Distribution Expenses
7.01
2.82
2.12
2.55
2.22
0.00
0.00
Other Expenses
-0.56
-0.29
-0.26
-0.35
-0.27
-0.21
-0.42
Total Expenditure (Excl Depreciation)
22.29
11.11
9.67
9.39
11.12
8.40
13.57
Operating Profit (PBDIT) excl Other Income
8
6.4
4.9
2.6
3.7
3.2
3.1
Other Income
0.83
0.04
0.32
0.01
0.00
-1.15
0.08
Operating Profit (PBDIT)
10.00
6.84
5.88
3.11
6.11
2.84
4.26
Interest
0.10
0.09
0.00
0.00
0.05
0.05
0.00
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
15.05
9.26
7.00
5.16
5.95
3.15
3.10
Depreciation
1.13
0.63
0.68
0.00
1.93
0.80
0.90
Profit Before Tax
8.78
6.12
5.20
2.58
5.28
1.99
3.36
Tax
2.41
1.55
1.64
0.73
1.57
0.83
0.99
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
6.62
4.83
3.56
1.91
3.84
1.18
2.45
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
6.62
4.83
3.56
1.91
3.84
1.18
2.45
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-0.01
0.00
-0.00
0.01
-0.00
-0.00
-0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
6.61
4.83
3.56
1.92
3.84
1.18
2.45
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.05
0.05
0.05
0.05
0.05
0.05
0.05
Reserves
30.78
30.83
29.76
25.96
25.94
21.27
18.75
Earnings per share (EPS)
0.11
0.08
0.06
0.03
0.06
0.02
0.04
Diluted Earnings per share
0.11
0.08
0.06
0.03
0.06
0.02
0.04
Operating Profit Margin (Excl OI)
26.51%
35.17%
33.55%
25.81%
28.16%
27.62%
19.69%
Gross Profit Margin
32.65%
38.5%
40.42%
21.49%
48.54%
24.15%
25.56%
PAT Margin
21.82%
27.54%
24.45%
15.91%
25.85%
10.21%
14.7%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Mar 2022 is 107.53% vs -12.57% in Mar 2021

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Mar 2022 is 83.33% vs 50.00% in Mar 2021

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Mar 2022 is 64.29% vs 33.33% in Mar 2021

stock-summary

Interest

YoY Growth in quarter ended Mar 2022 is 0.00% vs 0.00% in Mar 2021

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Mar 2022 has fallen from Mar 2021

Compare Quarterly Results Of Naturhouse Health SA With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(EUR)
Change(%)
Net Sales
30.33
56.39
-26.06
-46.21%
Other Operating Income
0.00
0.00
0.00
Total Operating income
30.33
56.39
-26.06
-46.21%
Raw Material Cost
15.28
2.78
12.50
449.64%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
5.48
0.00
5.48
Power Cost
0
0
0.00
Manufacturing Expenses
0.10
0.80
-0.70
-87.50%
Selling and Distribution Expenses
7.01
14.69
-7.68
-52.28%
Other Expenses
-0.56
2.54
-3.10
-122.05%
Total Expenditure (Excl Depreciation)
22.29
43.64
-21.35
-48.92%
Operating Profit (PBDIT) excl Other Income
8.04
12.75
-4.71
-36.94%
Other Income
0.83
14.71
-13.88
-94.36%
Operating Profit (PBDIT)
10.00
26.10
-16.10
-61.69%
Interest
0.10
0.80
-0.70
-87.50%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
15.05
53.61
-38.56
-71.93%
Depreciation
1.13
2.00
-0.87
-43.50%
Profit Before Tax
8.78
23.35
-14.57
-62.40%
Tax
2.41
-0.02
2.43
12,150.00%
Provisions and contingencies
0.00
0
0.00
Profit After Tax
6.62
23.37
-16.75
-71.67%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
6.62
23.37
-16.75
-71.67%
Share in Profit of Associates
0.00
0
0.00
Minority Interest
-0.01
0.00
-0.01
Other related items
0.00
0.00
0.00
Consolidated Net Profit
6.61
23.37
-16.76
-71.72%
Equity Capital
0
0
0.00
Face Value
0.05
0.60
0.00
Reserves
30.78
201.53
-170.75
-84.73%
Earnings per share (EPS)
0.11
1.33
-1.22
-91.73%
Diluted Earnings per share
0.11
1.33
-1.22
-91.73%
Operating Profit Margin (Excl OI)
26.51%
16.66%
0.00
9.85%
Gross Profit Margin
32.65%
44.95%
0.00
-12.30%
PAT Margin
21.82%
41.44%
0.00
-19.62%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 3.03 Million
in Mar 2022

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2022 is 73.14%

stock-summary

YoY Growth in quarter ended Mar 2022 is 107.53% vs -12.57% in Mar 2021

Quarterly - Consolidate Net Profit
Consolidate Net Profit 0.66 Million
in Mar 2022

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2022 is 37.50%

stock-summary

YoY Growth in quarter ended Mar 2022 is 83.33% vs 50.00% in Mar 2021

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 0.92 Million
in Mar 2022

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2022 is 35.29%

stock-summary

YoY Growth in quarter ended Mar 2022 is 64.29% vs 33.33% in Mar 2021

Quarterly - Interest
Interest 0.01 Million
in Mar 2022

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2022 is 0.00%

stock-summary

YoY Growth in quarter ended Mar 2022 is 0.00% vs 0.00% in Mar 2021

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 26.51%
in Mar 2022

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2022 has fallen from Jun 2021

stock-summary

YoY Growth in quarter ended Mar 2022 has fallen from Mar 2021